Glutamine.
Research-backed amino acid with potential health benefits. Feeds the cells lining your gut and the fast-dividing immune cells, and shuttles nitrogen between muscle, gut and kidney. Demand for it climbs when training or stress runs high.
Reviewed March 2026
- Category
- Amino acid
What Glutamine is, and what it does.
- Does it work
- Suits people in a heavy training block, anyone eating light on protein, and anyone focused on the gut lining. If protein intake is generous, your body already makes plenty.
- How much to take
- Start with 2,000mg to 5,000mg a day, the daily maintenance band, stirred into water. The 15,000mg used in trials is a research condition, usually split across the day.
- Time to feel it
- Digestive comfort tends to shift over one to two weeks of daily use. There's no same-day hit, because it works as a fuel and a nitrogen carrier, not a stimulant.
- The first dose
- A quiet day. It dissolves tasteless in water and absorbs quickly, and much of that first dose is burned by your intestinal cells before it reaches the bloodstream.
- With regular use
- 1-2 weeks for gut, ongoing for recovery
- How well tolerated
- Well tolerated at everyday amounts, with occasional bloating at the top of the band. Check with your clinician first if your liver or kidney function is being monitored.
- How it feels
- Neutral going down. Some people notice steadier digestion after a couple of weeks; for most it shows up in recovery and gut comfort rather than as a sensation.
- The overlooked benefit
- It donates the glutamate that starts glutathione synthesis, so it quietly supports your antioxidant network as well as the gut lining everyone buys it for.
5,000 to 10,000mg a day is where Glutamine works.
Source: Cruzat 2018 review + Rao 2012 gut study
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Glutamine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Gut barrier integrityRandomised trial
- Immune resilience through heavy trainingRandomised trial
- Muscle soreness and recovery after exerciseMeta-analysis
- Glutathione synthesis substrateNarrative review
- Nitrogen transport between organsNarrative review
Questions people ask about Glutamine.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Should I take it on an empty stomach?
- Most amino acids absorb better on an empty stomach since they don't compete with food proteins for absorption. 30 minutes before meals is ideal.
- Can I get enough from protein?
- If you eat enough protein (0.8-1g per pound bodyweight), you probably get enough aminos. Supplementing specific ones only makes sense for targeted goals.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Who benefits most from this?
- People with a specific, evidence-backed need. Glutamine has strong research. If your situation matches the studied use case, it's one of the more reliable supplements you can take.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Glutathione is assembled from glutamate, cysteine and glycine, and glutamine is the body's main circulating carrier of the glutamate portion. Supplying glutamine and glycine together covers two of the three residues the synthesis enzymes draw on.
Cysteine availability sets the pace of glutathione synthesis, and NAC is the stable way to deliver it. Glutamine feeds the glutamate side of the same tripeptide, so the pair covers both the bottleneck residue and its partner.
Glutamine is the preferred respiratory fuel of the cells lining the small intestine and feeds the tight-junction proteins those cells build. Lactobacillus strains act on the luminal side by competing for adhesion sites and acidifying the local environment, so the two reach the barrier from opposite faces.
Colonocytes run mainly on butyrate while small-intestine enterocytes run mainly on glutamine, so the pair covers the energy demand along the length of the lining. Both also feed tight-junction protein expression in the cells they fuel.
Gut enterocytes convert glutamine to citrulline, which the kidney turns into arginine, so glutamine is an upstream source of the arginine pool. Supplying both covers the route at two points.
Glutamine is deamidated to glutamate, one of the three amino acids ligated into glutathione. Glutamine availability therefore sets part of the ceiling on glutathione synthesis.
Glutathione needs glutamate from glutamine plus cysteine plus glycine, and cysteine is usually the rate limiting one. Pairing the two supplies both of the scarce inputs.
Alanine and glutamine are the two main carriers moving amino nitrogen between muscle, gut and liver. Clinical formulations use the alanyl-glutamine dipeptide because it is far more stable in solution than free glutamine.
Pyridoxal phosphate is the cofactor for the transaminases that move the glutamate carbon skeleton derived from glutamine into other amino acids. Without it the nitrogen handoff stalls.
Zinc supports tight junction protein expression while glutamine is the preferred fuel of the enterocyte itself. Gut formulas combine the two because they act on the barrier from different angles.
Leucine triggers mTORC1 while glutamine both supplies nitrogen for that synthesis and helps leucine enter the cell through the coupled SLC1A5 and LAT1 exchange. The transport coupling is the mechanistic link.
Glutamine fuels the small intestinal enterocyte while fermented inulin yields the short chain fatty acids that fuel the colonocyte. The pair covers both halves of the gut lining.
HMB, arginine and glutamine are packaged together in a preparation studied before cardiac surgery, with inflammatory and recovery measures as endpoints. The three are given as a fixed blend, so no study isolates the glutamine contribution. Read the pairing as a formulation with clinical study behind the blend rather than behind the pair.
Enterocytes take up glutamine and convert it through ornithine to citrulline, which leaves the gut and is picked up by the kidney for arginine synthesis. Circulating citrulline is used clinically as a readout of enterocyte mass for that reason. Glutamine sits upstream of citrulline rather than beside it.
Glutaminase strips the amide nitrogen to give glutamate, and glutamate dehydrogenase or a transaminase then yields alpha-ketoglutarate, which enters the citric acid cycle. That is how glutamine becomes fuel for gut and immune cells. Supplying alpha-ketoglutarate enters the same pathway one step later.
Glutamine is the body's main carrier of ammonia between tissues, and ornithine is the recycling hub of the urea cycle that finally disposes of it. The two sit on the same nitrogen-handling route at different points. Ornithine is also the intermediate through which gut glutamine becomes citrulline.
Glutamine is carried across the enterocyte brush border by sodium-coupled transporters, and that coupling pulls water and sodium with it. Oral rehydration formulations containing glutamine or the alanyl-glutamine dipeptide are built on this. Without sodium the transport driving force is not there.
Whey carries a substantial share of glutamine and glutamate residues within its peptides, released during digestion. Anyone already taking whey is taking bound glutamine, which matters when totalling intake. The free amino acid differs mainly in how quickly it appears in plasma.
Glutamine is the preferred respiratory fuel of the enterocyte, so it supports the energy side of epithelial turnover. Saccharomyces boulardii acts on the luminal side, on the microbial community and on the mucus layer. The two work on different sides of the same barrier and are commonly combined in gut formulations.
Zinc-carnosine adheres to the gastric and intestinal surface and releases zinc locally, while glutamine feeds the epithelial cells underneath. Both appear together in gut-lining products for that division of labour. The pairing is formulation logic supported by each component separately, not by a trial of the pair.
Bovine colostrum supplies immunoglobulins and growth factors that act at the epithelial surface, while glutamine supplies the fuel for cells with a two to three day turnover. They are frequently combined in intestinal barrier products. Each has its own literature; the combination has little.
Lactoferrin binds free iron in the gut lumen and interacts with the epithelial surface, while glutamine is consumed by that epithelium as fuel. Both are milk-derived components used in barrier-support formulations. The rationale is mechanistic rather than from a combination trial.
Glutamine is the dominant fuel for the small intestinal enterocyte, whereas the colonocyte runs mainly on butyrate made by bacterial fermentation. Galactooligosaccharides feed the fermentation that makes that butyrate. Together they cover fuel supply along the length of the gut rather than at one point.
Slippery elm mucilage forms a viscous layer over the mucosal surface; glutamine acts inside the cells beneath it. The pairing is long-standing in herbal gut blends and rests on the two acting at different places. No clinical work tests them together.
Marshmallow root is another mucilaginous botanical used for surface coating in the same formulations that carry glutamine. The rationale is physical coverage alongside cellular fuel. Evidence is traditional use and mechanism, not trial data.
Nothing specific on file for Glutamine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Glutamine actually does.
Glutamine is the most plentiful free amino acid in your blood and your muscle. You normally make plenty on your own, but during long stretches of metabolic stress your supply can fall short, which is why it gets called conditionally indispensable.
Glutamine synthetase clips free ammonia onto glutamate using ATP and magnesium. That makes glutamine your body's main non-toxic courier for nitrogen moving between muscle, gut, liver and kidney.
In your intestine and kidney, glutaminase takes that nitrogen back off again. The glutamate left behind gets converted to alpha-ketoglutarate, which drops into the citric acid cycle as fuel.
Gut lining cells and fast-dividing immune cells pull glutamine in quickly and burn it as a primary fuel, so demand climbs whenever either population is turning over fast.
Where Glutamine comes from.
Bacteria are fed sugar in a large tank and grown under conditions that make them release glutamine into the liquid around them. The cells are filtered out, the glutamine is captured on a resin and then crystallised at low temperature, because heat breaks it down. The dipeptide versions take that finished glutamine and attach a second amino acid so it survives in liquid.
Built by fermentation, the same way vitamin B12 and many amino acids are made at scale. Controlled conditions, consistent output.
Glucose from starch hydrolysis, or cane and beet molasses, plus an ammonium nitrogen source such as ammonium sulfate or ammonia gas.
Corynebacterium glutamicum or a related producer strain is grown in stirred aerated tanks under controlled biotin and ammonium conditions that push excretion of glutamine into the broth rather than glutamate.
Cells are removed by filtration or centrifugation and the clarified broth is passed over ion exchange resin that binds the amino acid and lets the rest through.
The eluate is concentrated under vacuum at low temperature, since heat drives cyclisation to pyroglutamate, and L-glutamine is crystallised, washed, then usually recrystallised.
Batches are assayed for identity and content by chromatography with optical rotation confirming the L-isomer, and pyroglutamate is limited as the marker degradant.
Dried crystals are milled and either filled directly or, for the dipeptide forms, coupled enzymatically or chemically with alanine or glycine and purified again.
Getting Glutamine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooling 10 placebo-controlled trials in 352 adults, glutamine showed no detectable change in intestinal permeability overall, with a reduction seen only in the subgroup taking more than 30 g a day for under two weeks.Meta-analysis. Abbasi et al., 2024 (Amino Acids). PMID 39397201 ↗
- Across 25 pooled trials in adult athletes, glutamine showed no detectable effect on immune cell counts, aerobic capacity or body composition, and was associated with a small weight reduction of about 1.4 kg.Meta-analysis. Ramezani Ahmadi et al., 2018 (Clinical Nutrition). PMID 29784526 ↗
- In 16 healthy adults, 0.3 g per kg of L-glutamine daily for 72 hours after eccentric knee exercise lowered muscle soreness ratings (2.6 versus 3.9 at 48 hours) and sped the return of knee extensor peak torque.Randomised trial. Legault et al., 2015 (International Journal of Sport Nutrition and Exercise Metabolism). PMID 25811544 ↗
- Pooling randomised trials, glutamine supplementation was linked to small reductions in C-reactive protein and some other cardiometabolic markers, with several lipid measures showing no detectable difference.Meta-analysis. Hasani et al., 2021 (BMC cardiovascular disorders). PMID 33865313 ↗
- In older adults, daily glutamine was tolerated as well as placebo over the trial, with no difference detected in reported side effects or routine laboratory measures.Randomised trial. Nóbrega et al., 2024 (Brazilian journal of medical and biological research). PMID 38808890 ↗
- The pooled analysis of glutamine supplementation in adults with major burns reports the effect estimates across trials and notes their heterogeneity.Meta-analysis. Tao W et al., 2024 (Journal of Burn Care and Research). PMID 38243579 ↗
- With trial sequential analysis applied, the authors report that the accumulated evidence on glutamine in severe adult burn injury does not yet reach the information size their analysis required.Systematic review. Ortiz-Reyes L et al., 2023 (Critical Care Medicine). PMID 37114912 ↗
- The review examined arginine and glutamine supplementation against transthyretin concentrations, a protein status marker rather than a clinical outcome.Systematic review. Linden MA et al., 2022 (Nutrition). PMID 35653933 ↗
- Across trials of enterally or parenterally fed critically ill adults, the review reports effects on circulating inflammatory markers; markers, not clinical endpoints.Systematic review. Gholamalizadeh M et al., 2022 (JPEN: Journal of Parenteral and Enteral Nutrition). PMID 34213769 ↗
- The review pools glutamine trials reporting inflammatory and oxidative stress indices in adults with long-term health conditions and reports mixed direction across indices.Systematic review. Movahed S et al., 2026 (Amino Acids). PMID 42366260 ↗
- The authors conclude the clinical trial base for glutamine in adults with long-standing gut inflammation is small and inconsistent rather than settled either way.Systematic review. Severo JS et al., 2021 (Clinical Nutrition ESPEN). PMID 33745622 ↗
- A double-blind randomised design tested oral alanyl-glutamine added to standard care in hospital-managed adults with acute gut illness.Randomised trial. Warren CA et al., 2023 (BMJ Open). PMID 37474181 ↗
- In immune-challenged weanling pigs, dietary arginine and glutamine changed growth performance and immune status measures.Animal study. Wellington MO et al., 2023 (Journal of Animal Science). PMID 37140541 ↗
- Dietary L-glutamine altered growth performance and carcass characteristics in Hanwoo heifers, with hepatic metabolic changes reported alongside.Animal study. Jin XC et al., 2025 (Journal of Animal Science). PMID 40592805 ↗
- Oral glutamine was given to dogs with parvoviral enteritis and clinical recovery measures were recorded in a veterinary setting.Animal study. Melo AMC et al., 2026 (Topics in Companion Animal Medicine). PMID 41354382 ↗
These are the studies our verdict leans on, chosen from the 58,988 we read for Glutamine. The full linked list is below.
The studies, linked.
12 sources behind our Glutamine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Multicentre, Randomized, Open-label, Phase III Study Comparing the Efficacy of Oral Glutamine and Calcium-magnesium With Calcium-magnesium Alone in the Prevention of Oxaliplatin-induced Neurotoxicity in Patients With Colorectal Cancer Treated With Oxaliplatin in Adjuvant or 1st Line Metastatic Settings.ClinicalTrials.gov ↗PHASE3 · 200 participants · Completed
- Clinical trialPhase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU PatientsClinicalTrials.gov ↗PHASE3 · 150 participants · Completed
- Clinical trialComparison of Effect of Enteral Versus Parenteral Glutamine Supplement on Intestinal Permeability and Outcome of Critically Ill PatientsClinicalTrials.gov ↗PHASE4 · 90 participants · Terminated
- Clinical trialSafety and Efficacy of Glutamine in Preventing Vaso-occlusive Crisis Among Sickle Cell Disease Patients: Randomized Controlled StudyClinicalTrials.gov ↗PHASE4 · 60 participants · Completed
- Clinical trialEffect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical TrialClinicalTrials.gov ↗NA · 40 participants · Completed
- Clinical trialExamining The Effect Of Ketamine On Glutamate/Glutamine CyclingClinicalTrials.gov ↗EARLY PHASE1 · 36 participants · Completed
- Clinical trialEffects Of Standard And/Or Glutamine Dipeptide And/Or Omega-3 Fatty Ascid-Supplemented Parenteral Nutrition On Neutrophil Functions, Interleukin-8 Level And Length Of Stay-A Double Blind,Controlled, Randomized StudyClinicalTrials.gov ↗PHASE4 · 36 participants · Completed
- Clinical trialCombination of Arginine, Glutamine, and Omega-3 Fatty Acid Supplements for Perioperative Enteral Nutrition in Surgical Patients With Gastric Adenocarcinoma or Gastrointestinal Stromal Tumor (GIST)ClinicalTrials.gov ↗NA · 34 participants · Completed
- Clinical trialA Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell CarcinomaClinicalTrials.gov ↗EARLY PHASE1 · 3 participants · Terminated
- Clinical trialEffects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot TrialClinicalTrials.gov ↗PHASE3 · 1,201 participants · Unknown
- Clinical trialEfficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury: a Single-center, Open-label, Randomized Controlled StudyClinicalTrials.gov ↗PHASE2 · 150 participants · Recruiting
- Clinical trialIn Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells in Healthy Subjects Using Stable Isotope Resolved Metabolomics: A Pilot StudyClinicalTrials.gov ↗NA · 20 participants · Recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 11,303 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Glutamine is, not how risky it is. A report is not proof Glutamine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.




